Main article

The nation’s second largest testing provider ended 2009 in strong fashion, with fourth-quarter revenues up 3.4 percent to $1.16 billion, and full-year revenues climbing 4 percent to $4.69 billion. This is solid growth for LabCorp (Burlington, N.C.), particularly compared to fourth-quarter and full-year results from the industry leader, Quest Diagnostics (Madison, N.J.)—which reported fourth-quarter revenue growth of 2.7 percent to $1.8 billion and full-year revenue growth of 2.8 percent to $7.5 billion. …

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

March 2010 - Table of Contents

Industry Buzz: MedPAC Considers Removing Some Lab Tests from In-Office Ancillary Services Exception

Lab Index Continues Winter Slump; Down 10% Over Last Five Weeks

Time Ticking as Physician Fee Cut Freeze Expires on March 1; Congress’s Next Move Remains Unclear

Carilion-Spectrum Merger to Shake Up Lab Industry’s Duopolistic Stronghold in Mid-Atlantic and Southern Regions

LabCorp’s Q409 Revenues Up 3.4% to $1.16 Billion; Economy Still Challenges Volume Growth in 2010

Inside the Lab Industry: Managing Risk in Lab Sales and Marketing: Nine Rules to Sell By

Bostwick Shutters AIPL after Only Six Months; Announces Tenn. Closure

Myriad Genetics Emerges as Early Leader in G-2’s Preliminary FY09 Benchmarking Analysis

Baylor Health Care Launches Joint Venture with US Oncology

Oral Arguments Heard in Gene Patents Lawsuit

LIR March 2010 (Full PDF Issue)